🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Adam Bisaga

Columbia University

ORCID: 0000-0003-4243-6462
MedicineNeurosciencePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study”.

Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107148
N/A
0.216DataRank · unranked
3 citations

Matisyahu Shulman, Onumara Opara, Kenzie M. Potter, Delia Voronca, Hiwot M. Tafessu +12 more

Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach

Addiction Biology(2023)10.1111/adb.13271
N/A
0DataRank · unranked
10 citations

Laís F. Berro, Gilberto Gerra, Leonardo Tadonio, Adam Bisaga, Thiago Marques Fidalgo +1 more

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk

BMJ Mental Health(2023)10.1136/bmjment-2023-300728
N/A
0DataRank · unranked
15 citations

Kevin Y. Xu, Adam Bisaga, Frances R. Levin, Thiago Marques Fidalgo, Richard A. Grucza +1 more

Patient Characteristics of Fentanyl Positive Individuals With Opioid Use Disorder

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110398
N/A
0DataRank · unranked
0 citations

Mei‐Chen Hu, Matisyahu Shulman, Kathryn Hefner, Onumara Opara, Kenzie M. Potter +5 more

Association of Baseline Fentanyl Use and Opioid Withdrawal Symptoms During Inpatient Buprenorphine Initiation in a Large Multisite Detoxification Trial

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110457
N/A
0DataRank · unranked
0 citations

Miranda Greiner, Mei‐Chen Hu, Onumara Opara, Kenzie M. Potter, Kaitlyn Ohrtman +3 more

Prescription Amphetamines in People With Opioid Use Disorder and Co-Occurring Psychostimulant Use Disorder Initiating Buprenorphine: An Analysis of Treatment Retention and Overdose Risk

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.109962
N/A
0DataRank · unranked
0 citations

Kevin Y. Xu, Adam Bisaga, Frances R. Levin, Thiago Marques Fidalgo, Richard A. Grucza +1 more

Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder

Addiction(2023)10.1111/add.16374
N/A
0DataRank · unranked
0 citations

Miranda Greiner, Adam Bisaga, Matisyahu Shulman